Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06247254 · ClinicalTrials.gov registry record · NA
Telehealth-Enhanced Assessment and Management
A NA study of Blood Pressure, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 1
- Study location
NCT06247254: Active NA study of Blood Pressure, sponsored by Wake Forest University Health Sciences.
NCT06247254 is a NA study of Blood Pressure that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 86 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06247254, a NA study of Blood Pressure, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 1
- Study location
Study Summary
TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.
Primary Outcome
Systolic blood pressure will be calculated as the average of the second and third of 3 successive measures by the research coordinator according to standard protocols at 6 months (Study Visit 3).
Conditions Studied
Interventions
- BEHAVIORAL Intensive Clinic Management
- BEHAVIORAL Intensive Tailored Telehealth Management
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2028-07 |
| Phase | NA |
What the registry record for NCT06247254 still lists
NCT06247254 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Intensive Clinic Management is the first listed.
NCT06247254 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06247254 about?
NCT06247254 is a clinical study titled "Telehealth-Enhanced Assessment and Management". TEAMS-BP is a Patient-Centered Outcomes Research Institute (PCORI)-funded trial under the Phased Large Awards for Comparative Effectiveness Research (PLACER) funding mechanism to evaluate two comprehensive and evidence-based strategies for managing blood pressure (BP) following stroke.
What is the current status of trial NCT06247254?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2024-11-15. Estimated completion is 2028-07.
What conditions does trial NCT06247254 study?
This clinical trial studies the following conditions: Blood Pressure.
What interventions are being tested in trial NCT06247254?
The interventions under investigation include: Intensive Clinic Management (BEHAVIORAL), Intensive Tailored Telehealth Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT06247254?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06247254 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06247254's enrollment target sits among peer trials
86 42nd of 101 higher than 60 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI